Activity of Broadly Neutralizing Antibodies, Including PG9, PG16, and VRC01, against Recently Transmitted Subtype B HIV-1 Variants from Early and Late in the Epidemic

For the development of a neutralizing antibody-based human immunodeficiency virus type 1 (HIV-1) vaccine, it is important to characterize which antibody specificities are most effective against currently circulating HIV-1 variants. We recently reported that HIV-1 has become more resistant to antibod...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Euler, Zelda, Bunnik, Evelien M., Burger, Judith A., Boeser-Nunnink, Brigitte D. M., Grijsen, Marlous L., Prins, Jan M., Schuitemaker, Hanneke
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2011
Assuntos:
Pathogenesis and Immunity
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3126573/
https://ncbi.nlm.nih.gov/pubmed/21561918
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.00196-11
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados